CURRICULUM VITAE
Name : Mohamad H. Qari
D.O.B : 23 March 1964
Place of Birth : Makkah, Saudi Arabia
Nationality : Saudi
Marital Status : Married has two daughters
Current Position : - Consultant and Professor of Hematology. - President of the Saudi Scientific Hematology Society - Deputy Director of the Center of Excellence for Osteoporosis Research
Contact Address : Prof. Mohamad H. Qari, FRCPA, FACP. Hematology Department. King Abdul Aziz University Hospital P.O. Box . 80215, Jeddah , 21589. Saudi Arabia.
PHONE/FAX (HOME) : 00966 26291080. (OFFICE) : 00966 26408486. (MOBILE) : 00966 505619674.
E-mail : [email protected]
EDUCATIONAL QUALIFICATION:
High School : King Abdulaziz High School, Makkah, Saudi Arabia. Medical School : College Of Medicine King Abdulaziz University Jeddah, Saudi Arabia. Degree Awarded : M.B, Ch. B. Grade : Very Good. Date Degree Awarded : 4th July, 1987. Post Graduate Degree : FRCPA (Hematology) Fellowship of The Royal College of Pathologists of Australasia FACP-Fellow of the American College of Physicians
Date Qualified : August 1996.
POST GRADUATE CAREER:
* May 2004- Date Promoted to Associate Professor.
* Oct 1997- April 2004 Consultant and Assistant Professor of Hematology College of Medicine, King Abdulaziz University Jeddah, Saudi Arabia.
* Oct. 1998 – Oct 2002 Chairman/ Department of Hematology Consultant and Assistant Professor of Hematology College of Medicine, King Abdulaziz University Jeddah, Saudi Arabia.
*Sept. 1991 -Sept.1996 Residency training Program of (RCPA Riyadh Saudi Arabia, including combined clinical and Laboratory duties and one year in the bone Marrow Transplant Unit of Riyadh Military Hospital
* Aug. 1987 – July.1988 : Internship Year. King Abdulaziz University Hospital. Jeddah, Saudi Arabia.
DUTIES AND AFFILIATIONS:
1. Member of the International Academy of Pathology-Arab Division.
2. President of the Saudi Scientific Hematology Society
3. Founding Member/ Saudi Society of Laboratory Medicine.
4. Founding Member/ Saudi Society of Transfusion Medicine.
5. Member of the Research Board of Advisors: The American Biographical Institute,
USA.
6. Member of the Association for Medical Education in Europe (AMEE).
7. Head of the Hospital Laboratory Quality Improvement Committee
8. Member of the National Arab American Medical Association.
9. Member of the Saudi Thalassemia Society, and Head of the Transfusion Committee of
the Society. 10. Member of Al-Eman Charity Society and Cancer Support Network.
11. Member of the International Society of Blood Transfusion.
12. Member of the Saudi Pediatric Hematology Oncology Society (SAPHOS)
13. Member of the Gulf Region Hemostasis Working Group.
14. Peer reviewer for the Saudi Medical Journal.
15. Peer reviewer for the projects funded by King Abdul Aziz City for Science and
Technology
16. Locum Consultant Hematologist, Armed Forces Hospital, Khamis Mushayt.
17. Lecturing in the College of Medicine for the Under-graduates, Post-graduate and the
Post-graduate Residency Training Program.
18. Lecturing in the Medical Technology school.
19. Participated in the organizing committee of several symposia and workshops.
20. Locum Consultant Hematologist, Armed Forces Hospital, Wadi Aldawasir.
21. In-Charge of Hematology Laboratory Heat Stroke Center - during the Pilgrimage
Season of the year 1989.
22. Resident of the Year during the Academic Year 1995.
23. Inspector for the College of American Pathologists (CAP)-Laboratory Accreditation
Committee
List of Publications Of Prof. Mohamad H. Qari
1. Patterns of Deep Vein Thrombosis in Jeddah Area-Western Saudi Arabia. Al zahrani H, Qari MH, Sejeny SA. INTERNATIONAL ANGIOLOGY, (1993) 12:54-58.
2. Acute Myeloblastic Leukemia (AML-M2) Expressing CD-19 B-cell Lymphoid Antigen Without Myeloid Surface Antigen. Khalil S.H, Qari MH, Jackson J.M, Pyle R.H. LEUKAEMIA RESEARCH, (1994) 18:145.
3. Immunophenotyping of Childhood Acute Lymphoblastic Leukemia In Saudi Arabia, Second Look. Khalil S.H, Qari MH, Jackson J.M, Pyle R.H, El Solh H, Al Nasser A, LEUKAEMIA RESEARCH, (1994) 18:881-883.
4. Sebastian Platelet Syndrome. Case Report. Khalil S.H, Qari MH, Jackson J.M, PATHOLOGY, (1995) 27: 197-198.
5. Parvovirus B19 infection Associated diseases, Common and Uncommon. Hussein Qadri S.M, Qari MH. POSTGRADUATE MEDICINE (1996) 100:239-252.
6. Vancomycin – Resistant Enterococci (VRE) As Intestinal Flora from poultry in Riyadh. Hussein Qadri S.M, Postle A.G, Qari MH, Quraishi M.A, ANNALS OF SAUDI MEDICINE, (1997) 17(5):553-554.
7. Bone Marrow Examination in the Staging of Lymphoma. Qari MH, Khalil S.H, Humaidan H. SAUDI MEDICAL JOURNAL, (1998) 19: 275-278.
8. Mutation of P16, p21 or cyclin dependent kinase 4 is rare in in acute lymphoblastic leukaemia. Qari MH, Khalil SH, Kambouris M. and Myers B . BRITISH JOURNAL OF HAEMATOLOGY (1998) 103:467-472.
9. Advances in transfusing blood and its components. Qari MH, LABORATORY MEDICINE; 1999, 1(1): 3-4.
10. Improving the diagnostic precision of bone marrow for haemophagocytic syndromes. Qari MH, and Roberts, G.T. LABORATORY HEMATOLOGY (1999) 5:37-42.
11. Point of care testing: Time to decentralize. Qari MH, LABORATORY MEDICINE; 2000, 1(4): 9-12.
12. The achievement in pilgrimage health care provision during the era of the custodian of the two holy mosques. Qari MH and Jamal YS. The proceedings book of the international conference on the achievements of the custodian of the two holy mosques KING FAHD BIN ABDULAZIZ. 26-28/8/1422. 11-14/11/2001, RIYADH, SAUDI ARABIA.
13. Influence of age ,sex, folate and vitamin B12 status on plasma homocysteine in Saudis. Ardawi MS, Rouzi AA, Qari MH, Dahlawi FM, Raddadi RM. SAUDI MED J. (2002) 23(8) : 959-968.
14. Pattern of change in thrombophilia parameters during normal pregnancy. Marzouki A, Fageeh W, Higazi M, Qari MH, Sibiani AS. Nazer S. SAUDI JOURNAL OF OBS. AND GYN. (2003)3(1):33-40.
15. Neonatal screening for Hemoglobinopathies using high-performance liquid chromatography. Al Jaouni SK, Qari MH, Damanhouri GA, Farouk MF. PROCEEDING OF THE SECOND ANNUAL SCIENTIFIC MEETING FOR RESEARCH AT KING ABDULAZIZ UNIVERSITY , Jeddah, Saudi Arabia. March 2003: 153-164.
16. The effect of magnetic field on the hematological parameters of mice. Qari MH. Accepted for publication on 22 March 2003, in OXFORD RESEARCH FORUM J.
17. The Effect of Magnetic field on the Boichemical Parameters of Mice Blood. Taha AK. & Qari MH. Pak J.S., January – March 2003:19 (1) 36-40.
18. Recent advances in the diagnosis and management of deep vein thrombosis: A regional consensus. Qari MH. Abdel Razek H, Alzeer A, Alizadeh H, Kristensen J, Al Sayegh F, Qutub H, Marashi M, Husten S, Mousa S. CURRENT OPIN. IN INVEST. DRUGS;2003,4(3):309-315.
19. Chromotography Phenotypes Distribution of Neonatal Thalassemia and Sickle Cell Anemia in Hospitals Births in Jeddah, Saudi Arabia: Soad K. Al-Jaouni, Mohamad H. Qari, Ghazi A. Damanhouri; Mohamed F. Fadallah and Jummanah M. Jurallah. EGYPTIAN J PEDIA; 2003,20 (3/4): 595-605.
20. Donor deferral pattern in a hospital based transfusion center. Qari MH. KING ABDUL AZIZ UNIV. MED J.2004:11.17-28.
21. Recent advances in the diagnosis and management of deep vein thrombosis: A regional consensus. Abdel Razek H, . Qari MH, Alzeer A, Alizadeh H, Kristensen J, Al Sayegh F, Qutub H, Marashi M, Husten S, Mousa S. METHODS MOL MED. 2004;93:267-92.
22. Hematological parameters and elements level in three different groups of thalassemia major. Jalauddin A. Khan, Mohamad H. Qari and Naif H. Al Sharif. BAHRAIN MEDICAL BULLETIN, Vol. 26, No. 2, June 2004.
23. High throughput coagulation analyzers. Qari MH. Combinatorial chemistry and high throughput screening; 2005,8 (4),353-360.
24. Recurrent intestinal perforation as a presentation of antiphospholipid syndrome. Aldagal S, Mansouri M. Qari MH, Sibiany A. ANN SAUDI MED 2006; 26(1):52-55
25. Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anemia: Al –Jaouni Soad K, Al Muhayawi Saad M, Qari Mohammad H, Abu Nawwas Mohammad, Al Mazrooa Adnan A. BAHRAIN MEDICAL BULLETIN 2006; 28(4)164-167.
26. Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial: Mohamad Hasan Qari, Soad Khalil Aljaouni, Mohamad Salleh Alardawi, Huda Fatani, Fatin Mohamad Alsayes, Panagiotis Zografos, Mohamad Alsaigh, Adnan Alalfi, Mohamad Alamin, Abdulilah Gadi, Shaker A. Mousa. THROMBOSIS AND HAEMOSTASIS; 2007, 982: 392-396.
27. The Effect of cigarette or sheesha smoking on first-trimester markers of Down Syndrome: Ardawi MSM, Nasrat HA, Rouzi AA, Qari MH, Al-Qatani MH, Abuzenadah AM. BRITISH J OBSTETRICS AND GYNAECOLOGY 2007 114(11):1397-401.
28. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM. PRENAT DIAGN. 2007 Apr;27(4):303-11.
29. The effect of cigarette or sheesha smoking on first-trimester markers of Down syndrome. MSM Ardawi, HA Nasrat, AA Rouzi, MH. Qari, MH Aluzenadah. BJOG AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNECOLOGY, Vol. 114, Issue 11, pages 1397-1401, November 2007.
30. The influence of exposure to light and dark environment on platelet concentrates during storage. Maha Hegazi and MH. Qari. BULL. ALEX. FAC. MED. 43 No.3, 2007.
31. Glucose-6-Phosphate dehydrogenase deficiency correlation between Genotype and Phenotype. Saod K. AL Jaouni, Mohammed H. Qari, Saad M. AL Muhayawi, Ibrahim M. Ashankyty and Jummanah M. S. Jarullah. JKAU: MED. SCI. Vol. 14 No.2, pp: 3-13 (2007 A.D. / 1428 A. H.)
32. Pattern of HB level rise during normal pregnancies. Maha Ibrahim, Mohamad Hasan Qari, Wafa Sait and Mansor Abulela. HEMOGLOBIN, 33 (6):534-538, (2009).
33. Infrared spectroscopy of human bone marrow: evidence of structural changes during acute leukemia. G. A. Raouf, W. F. Elkhateeb, H. Toumah, MH. Qari, S. Jaouni and K. Elkebba. INT. J. NANO AND BIOMATERIALS, Vol.2 Nos. 1/2/3/4/5, 2009.
34. Pharmacogenomics in osteoporosis: Steps toward personalized medicine. Robert Greene, Shaymaa S. Mousa, Mohamed Ardawi, Mohamed H. Qari and Shaker A. Mousa. PARMACOGENOMICS AND PERSONLAIZED MEDICINE 2009:2 1-10.
35. Management of painful Vaso-Occlusive crisis of Stickle-Cell anemia: Consensus Opinion. Shaker A. Mousa, A. K. Al-Momen, F. Al Sayegh, S. K. Jaouni, Z.A. Nasrullah, H. AL Saeed, A. Alabdullatif, M. Al Sayegh, H. Alzahrani, M. Higazi, A. Al Mohamadi, A. Alsuliman, A. Omer, S. AL Kindi, A. Tarawa, F. Alothman and MH. Qari. CLINICAL AND APPLIED THROMBOSIS/HEMAOSTASIS, Volume 16, Number 4, July/August 2010, 365-376.
36. Reference intervals of biochemical bone turnover markers for Saudi Arabian Women: A cross-sectional study. Mohammed-Salleh M. Ardawi, Abdulrauf A. Maimani, Talal A. Baksh, Abdulraheem A. Rouzi, Mohammed H. Qari and Rajaa M. Raddadi. BONE 47(4)Oct:2010:804-814.
37. Serum CA-125 correlates with staging, prognosis and survival of Non-Hodgkin Lymphoma (NHL). Tarek H. Ashour and Mohamad H. Qari. JOURNAL OF APPLIED HEMATOLOG, Volume 1 – Issue 1 - September 2010.
38. Assessment of bone metabolism and densitometry in sickle cell anemia. Mohamad Hasan Qari. JOURNAL OF APPLIED HEMATOLOGY Vol.1, Issue 2, December 2010.
39. Diagnosis and management of sickle cell disorders. Mousa SA, and Qari MH. METHODS MOL BIOL. 2010;663:291-307.
40. Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. M.-s. M. Ardawi, MH. Qari, A. A. Rouzi, A. A. Maimaniand R. M. Radadi. OSTEOPOROSIS INTERNATIONAL WITH OTHER METABOLIC BONE DISEASES, Volume 22, Number 2, Feb 2011;463-75
41. Flowcytometric Assessment of Leukocyte function in sickle cell anemia. Mohamad H. Qari and Wed A Zaki. (Accepted) HEMOGLOBIN, 19 Feb. 2011;35(4):367-81.
42. Determinants of serum sclerostin in healthy pre- and postmenopausal women. Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH. J BONE MINER RES. 2011 Dec;26(12):2812-22.
43. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Ardawi MS, Sibiany AM, Bakhsh TM, Qari MH, Maimani AA. OSTEOPOROS INT. 2012 Feb;23(2):675-86.
44. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease. Qari MH, Dier U, Mousa SA. CLIN APPL THROMB HEMOST. 2012 Mar-Apr;18(2):195-200.
45. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study. Ardawi MS, Al-Sibiany AM, Bakhsh TM, Rousi AA, Qari MH. OSTEOPOROS INT. 2012 Jun;23(6):1789-97.
46. High serum sclerostin predicts the occurrence of osteoporotic in postmenopausal women: The CEOR study. Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA. J BONE MINER RES. 2012 Jul26.doi:10.1002/jbmr.1718.
47. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: A cross- sectional and a longitudinal study. Ardawi MS, Rouzi AA, Qari MH. J CLIN ENDOCRINOL METAB. 2012 Augt 3.
48. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease. Qari MH, Dier U, Mousa SA. CLIN APLL THROMB HEMOST. 2012 Mar-Apr; 18(2): 195-200. doi: 10.117/ 1076029611420991. Epub.2011 Sep 23.
49. Physical activity in relation to serum sclerostin , insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. Ardawi MS, Rouzi AA, Qari MH. CLIN ENDOCRINOL METAB. 2012 Oct; 97 (10): 3691- 9. doi: 10.1210/jc.2011- 3361. Epub 2012 Aug 3.
50. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study. Ardawi MS, Al-Sibiany AM, Bakhsh TM, Rouzi AA, Qari MH. OSTEOPOROS INT. 2012 Jun ;23(6) :1789-97. doi : 10.1007/s00198-011- 1806-8. Epub 2011.
51. High Serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women : the center of excellence for osteoporosis research study. Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA. J BONE MINER RES. 2012 Dec ; 27 (12) :2592-602, doi : 10.1002/jbmr.1718
52. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins Qari MH, Streiff MB, Syrigos K, Bounameaux H. Buller HR, THROMB HAEMOST. 2013 Jan; 11(10:56-70. doi:10.1111/jth. 12070.
53. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer, Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Buller HR, Bounameaux H. THROMB HAEMOST. 2013 Jan; 11(1):71-80. doi: 10.1111/jth. 12071.
PRESENTATION IN CONFERENCES AND SYMPOSIA:
1- Plenary session: “Novel anticoagulants” Venous Thrombosis in Clinical Practice symposium: 22-23 April 2003, KAUH, Jeddah.
2- Presentation: ”The current status of ALL diagnosis in the western region”; 1st National Meeting for Standardization of Management of Childhood Acute Leukemia : 8 March 2003, King Faisal Specialist Hospital and Research Center, Riyadh, KSA.
3- Lecture :in the 4th Course of Transfusion Medicine: 21 December 2002 to 20 January 2003, King Fahd General Hospital, Jeddah.
3- Lecture : (the nursing care for the neutropenic patients) The nursing Oncology Course for Nurses: 21-25 December 2002, K.A.U.H., Jeddah.
4- Lecture during the Educational Program on Blood Donation: 19-23 October 2002, K.A.U.H., Jeddah.
5- Teaching session: Saudi Board Preparatory Course: 14 September 2002, KAUH, Jeddah.
6- Lecture: Blood substitutes Training Course in Transfusion Medicine: 1-29 January 2002, King Fahd General Hospital, Jeddah.
7- Proposal presentation: Tinzaparine in the management of the painful Vaso occlusive crisis of Sickle cell anemia ; 1st Consensus Meeting on Diagnosis and Treatment of VTE: 23-25 May 2001, Leo Pharmaceutical Products, The Jumeirah Hotel – Dubai.
8- APPRECATION:3rdINTERNATIONAL SYMPOSIUM ON HEMATOLOGY AND BLOOD TRANSFUION HELD ON 3-6-February 2001 At : 10 January– 09 February 2001, King Fahd General Hospital, KSA.
9- APPRECATION: Participation in Hematology Course which was held in the period from 4/10/2000 to 4/11/2000 in King Fahd General Hospital.
10- APPRECATION: participation at the "Intensive review course for saudi board and end of your exam held on 19-20 April 2000 and organized by Department of Surgery king Abdul Aziz University Hospital, Jeddah
11- Teaching during the Intensive Review Course for Saudi Board and End of Year Exam: 19-20 April 2000, K.A.U.H., Jeddah.
12- Presentation: P16 gene deletion in ALL; Second Jordanian Oncology Conference , Second Pan Arab cancer Conference, Fourth French Arab cancer Foundation Conference, Second Arab American Cancer Foundation Conference: 15-18 April 1998, The Royal Cultural Center, Amman, Jordan.
13- Poster: Screening of primary acute Lymphoblastic leukemia samples for the of mutations in the p16, p21 and presence CDK4 genes. American society of hematology meeting, November 1997, Orlando, Fl, USA
14- Presentation: The infrequent homozygous deletion of the p16 gene in acute lymphoblastic leukemia: Third Middle East oncology congress, 1-3 May 1997. Beirout, Lebanon.
15- Presentation: Bone marrow examination in the staging of lymphoma: International symposium on pathology and laboratory medicine, 15-17 November 1997, Jeddah Saudi-Arabia.
16- Presentation: Quantitative range of hemophagocytosis in hospital patients: Pathology update symposium, 2-5 November 1997, Riyadh, Saudi Arabia
17- Presentation: Bone marrow examination in the staging of lymphoma: International hematology/oncology symposium, 24-26 February 1997,Muscate, Oman.
18- Presentation: The normal range of hemophagocytosis in the bone marrow. Third Saudi oncology symposium, 21-23 October 1996. Riyadh, Saudi Arabia.
19- Presentation: The pattern of deep vein thrombosis in Jeddah area: Symposium on advances in thrombosis management:26-27 April 1992. Security Forces Hospital, Riyadh, Saudi Arabia.
In addition to numerous presentations and lectures in local and international symposia, meeting and post graduate courses.
Conferences and symposia attended:
1. VIII European Congress of the International Society of Blood Transfusion: 5-9 July 2003, Istanbul.
2. International Thalassaemia Workshop: 28th of October 2002, Jeddah.
3. Saudi Board Preparatory Course: 14 September 2002, KAUH, Jeddah.
4. Assessing Application of Knowledge and Written Tests and Objective Structured Clinical Exams Workshop: 28-30 October 2002, KFMRC-KAUH, Jeddah.
1) Medical Curriculum Development : 6-8 May 2002, Saudi Council for Health Specialties, KAUH, Jeddah.
2) Training Course in Transfusion Medicine: 1-29 January 2002, King Fahd General Hospital, Jeddah.
3) XVIth Meeting of the International Society of Haematology - European and African Division: Cairo 5-9 January 2002.
4) XVIII Congress of the International Society on Thrombosis and Haemostatic: 11 July 2001, Paris.
5) 1st Consensus Meeting on Diagnosis and Treatment of VTE,was held at the Jumeirah Beach Hotel- Dubai From 23-25 May 2001.
6) ATTENDANCE: Diagnostic Immunology Workshop held at King AbdulAziz University Hospital International Conference ON Advanced Medicine From 23-26 April 2001.
7) 3rd International Symposium on Hematology and Blood Transfusion: 3-6 February 2001, King Saud University College of Medicine & University Teaching Hospitals, Towaiq Palace, Diplomatic Quarter, Riyadh, KSA.
8) Diagnostic Immunology Workshop: 23-26 April 2001, KAUH, Jeddah, KSA.
9) 26th Congress of the International Society of Blood Transfusion: 9-14 July 2000, Austria Centre Vienna, Vienna.
10) SGH Bone Marrow Transplantation 2000: 20-21 November 2000, Saudi German Hospital Auditorium , Jeddah, KSA.
11) Basic and Clinical Aspects of Chemotherapy: 22 November 2000, King Faisal Specialist Hospital & Research Center, Jeddah.
12) 2nd Annual Hematology and Blood Transfusion Symposium: 12-15 February 2000, King Saud University College of Medicine and University Teaching Hospitals POSTGRADUATE CENTRE, Riyad, KSA.
13) Update in hematology & Transfusion Medicine Symposium: 3rd of March 1999, Saudi German Hospital Group, Jeddah, KSA.
14) CAP/LAP Inspector Training – Kingdom of Saudi Arabia: 21 March 1998, College of American Pathologist, 325 Waukegan Road Northfield, Illinois.
15) The 1st G.C.C. Blood Transfusion Conference: 28-30 September 1998, Abu Dhabi.
16) Second Jordanian Oncology Conference , Second Pan Arab cancer Conference, Fourth French Arab cancer Foundation Conference, Second Arab American Cancer Foundation Conference: 15-18 April 1998, The Royal Cultural Center, Amman, Jordan.
17) CAP/LAP Inspector Training – Kingdom of Saudi Arabia: 21 March 1998, College of American Pathologist, 325 Waukegan Road Northfield, Illinois.
18) International Symposium on Pathology and Laboratory Medicine: 15-17 November 1997, King Abdulaziz University, Jeddah.
19) Arab American Cancer Convention & The 3rd Annual Meeting of the Syrian Association of General Surgeons: 22-27 June 1997, The National Arab American Medical Association and The Syrian Association of General Surgeons, Damascus.
20) First International Haematology/Oncology Conference: 24-26 February 1997, Sultan Qaboos University, Muscat, Sultanate of Oman.
21) Third Saudi Oncology Symposium “Cancer Year of 2000”: 21-23 October 1996, King Faisal Specialist Hospital and Research Center, Riyadh, KSA.
22) Training Programme in Haematology: 11-13 March 1995, Research and Postgraduate Studies Centre, King Fahd Hospital, Jeddah.
23) Saudi Oncology Symposium 1994: 25-26 October 1994, King Fahd National Guard Hospital, Jeddah, KSA.
24) The Advanced Transfusion Medicine Course: 2-15 April 1994, King Fahd Medical Research Center, Jeddah, KSA.
25) Postgraduate Haematology Course: 15-16 November 1992, Riyadh Armed Forces Hospital, Riyadh, KSA.
26) Advances in Thrombosis Management: 26-27 April 1992, Security Forces Hospital, Riyadh, KSA.
27) Introduction to Computers: 10 February 1990, School of Health-Related Professions, The University of Alabama at Birmingham.
In addition to numerous presentations and lectures in local and international symposia, meeting and post graduate courses attended as part of the continuous professional development with certified credit hours.